Listen to the Latest Podcast!
Clinical Chemistry 0: clinchem.2009.136507v1, 2009; 10.1373/clinchem.2009.136507
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Supplemental Data and Journal Club
Right arrow All Versions of this Article:
clinchem.2009.136507v1
56/3/459    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiu, R. W.K.
Right arrow Articles by Lo, Y.M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiu, R. W.K.
Right arrow Articles by Lo, Y.M. D.
Related Collections
Right arrow Molecular Diagnostics and Genetics

Received on ,
Accepted on ,

Brief Communications

Maternal Plasma DNA Analysis with Massively Parallel Sequencing by Ligation for Noninvasive Prenatal Diagnosis of Trisomy 21

Rossa W.K. Chiu 1, Hao Sun 1, Ranjit Akolekar 2, Christopher Clouser 3, Clarence Lee 3, Kevin McKernan 3, Daixing Zhou 3, Kypros H. Nicolaides 2, Y.M. Dennis Lo 1*

1 Centre for Research into Circulating Fetal Nucleic Acids, Li Ka Shing Institute of Health Sciences, and Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
2 Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK
3 Life Technologies, Beverly, MA

* To whom correspondence should be addressed. E-mail: loym{at}cuhk.edu.hk.

BACKGROUND: Noninvasive prenatal diagnosis of trisomy 21 (T21) has recently been shown to be achievable by massively parallel sequencing of maternal plasma on a sequencing-by-synthesis platform. The quantification of several other human chromosomes, including chromosomes 18 and 13, has been shown to be less precise, however, with quantitative biases related to the chromosomal GC content.

METHODS: Maternal plasma DNA from 10 euploid and 5 T21 pregnancies was sequenced with a sequencing-by-ligation approach. We calculated the genomic representations (GRs) of sequenced reads from each chromosome and their associated measurement CVs and compared the GRs of chromosome 21 (chr21) for the euploid and T21 pregnancies.

RESULTS: We obtained a median of 12 x 106 unique reads (21% of the total reads) per sample. The GRs deviated from those expected for some chromosomes but in a manner different from that previously reported for the sequencing-by-synthesis approach. Measurements of the GRs for chromosomes 18 and 13 were less precise than for chr21. z Scores of the GR of chr21 were increased in the T21 pregnancies, compared with the euploid pregnancies.

CONCLUSIONS: Massively parallel sequencing by ligation of maternal plasma DNA was effective in identifying T21 fetuses noninvasively. The quantitative biases observed among the GRs of certain chromosomes were more likely based on analytical factors than biological factors. Further research is needed to enhance the precision for measuring for the representations of chromosomes 18 and 13.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
H. C. Fan, Y. J. Blumenfeld, U. Chitkara, L. Hudgins, and S. R. Quake
Analysis of the Size Distributions of Fetal and Maternal Cell-Free DNA by Paired-End Sequencing
Clin. Chem., August 1, 2010; 56(8): 1279 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. V. Voelkerding and E. Lyon
Digital Fetal Aneuploidy Diagnosis by Next-Generation Sequencing
Clin. Chem., March 1, 2010; 56(3): 336 - 338.
[Full Text] [PDF]